MENU
LBRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
LB Pharmaceuticals (LBRX) Earnings Date & Reports
LB Pharmaceuticals Inc is a late-stage biopharmaceutical company developing novel therapies for the treatment of a wide range of neuropsychiatric disorders including schizophrenia, bipolar depression, adjunctive treatment of depressive disorder and other diseases... Show more
A.I. Advisor
published Earnings
LBRX is expected to report earnings to rise 16.42% to -77 cents per share on September 02
Q2'26
Est.
$-0.78
Q1'26
Missed
by $0.17
Q4'25
Beat
by $0.13
The last earnings report on May 12 showed earnings per share of -67 cents, missing the estimate of -50 cents. With 513.12K shares outstanding, the current market capitalization sits at 858.58M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information